You just read:

New data presented at American Heart Association (AHA) show dabigatran-specific antidote idarucizumab* restores blood clotting mechanism in humans

News provided by

Boehringer Ingelheim (Canada) Ltd.

Nov 26, 2014, 08:00 ET